Physician profile

Valeri Koganski

Internal Medicine · Langhorne, PA

NPI 1285696948

$17,082.46

in general payments reported to CMS, 2019-2025

69 companies · $2,016 in 2025

The $2,016 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,405.64

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,786.97 2019-2025
Novo Nordisk INC $1,571.12 2019-2025 Wegovy, Ozempic, Rybelsus
Lilly USA, LLC $1,459.58 2019-2025 Mounjaro, Zepbound, Jardiance
Amgen INC. $1,212.07 2019-2025 Evenity, Prolia, Repatha
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $1,139.91 2019-2025 Xifaxan, Cycloset
Astrazeneca Pharmaceuticals LP $922.40 2019-2025 Airsupra, Farxiga, Breztri
Radius Health, INC. $721.91 2019-2025 Tymlos
Pfizer INC. $675.37 2019-2025
Glaxosmithkline, LLC. $515.52 2019-2023 Shingrix, Trelegy Ellipta, Bexsero
Mylan Specialty L.P. $482.50 2019-2024 Yupelri
Novartis Pharmaceuticals Corporation $479.94 2019-2024
Boehringer Ingelheim Pharmaceuticals, INC. $467.27 2019-2024 Jardiance
Astellas Pharma US INC $443.85 2019-2025 Veozah, Myrbetriq
Bayer Healthcare Pharmaceuticals INC. $443.03 2022-2025
Vivus LLC $378.47 2019-2025 Qsymia, Pancreaze
Show all 69 companies
CompanyGeneral paymentsYearsTop products
Amarin Pharma, INC. $359.80 2019-2022
Merck Sharp & Dohme LLC $353.47 2019-2023 Verquvo, Belsomra, Steglatro
Corcept Therapeutics $343.99 2023-2025 Korlym
Abbott Laboratories $329.48 2021-2025 Freestyle Libre 3, Proclaim
Exact Sciences Corporation $233.36 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Takeda Pharmaceuticals U.S.A., INC. $197.22 2019-2024 Gattex
Esperion Therapeutics, INC. $181.62 2021-2025 Nexletol
Viatris Specialty LLC $180.10 2025 Yupelri
Teva Pharmaceuticals USA, INC. $177.27 2019-2022
Eisai INC. $137.59 2020-2021
Heartflow, INC. $129.33 2025
Shire North American Group INC $119.53 2019
Alexion Pharmaceuticals, INC. $115.30 2020-2024 Ultomiris
Verona Pharma, INC. $114.46 2025 Ohtuvayre
Avanir Pharmaceuticals, INC. $112.80 2019-2021
Almatica Pharma LLC $100.21 2024-2025 Teriparatide
Sumitomo Pharma America, INC. $89.02 2024-2025 Gemtesa
Sunovion Pharmaceuticals INC. $85.61 2019-2021
Boston Scientific Corporation $73.75 2024-2025 General - Dbs, Bodyguardian
Inspire Medical Systems, INC. $70.41 2024 Inspire
Daiichi Sankyo INC. $66.98 2022
Biohaven Pharmaceutical Holding Company LTD. $65.41 2022
E.R. Squibb & Sons, L.L.C. $54.32 2020-2024 Eliquis, Camzyos
Seqirus USA INC $39.08 2019
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $38.66 2019
Edwards Lifesciences Corporation $38.22 2023-2024 Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Xeris Pharmaceuticals, INC. $32.69 2025 Recorlev
Tactile Systems Technology INC $31.76 2024 Entre Plus, Flexitouch Plus
Intra-Sana Laboratories $30.80 2023 Reltone 200 Mg, Reltone 400 Mg, Glycate
Digestive Care, INC. $30.13 2025 Pertzye
Allergan, INC. $27.12 2019
Pulmonx Corporation $25.78 2025 Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve
Horizon Therapeutics Plc $24.61 2019
Cumberland Pharmaceuticals, INC. $23.41 2023 Kristalose
Scilex Pharmaceuticals INC. $20.46 2020
Regeneron Healthcare Solutions, INC. $20.41 2024 Evkeeza
Ultragenyx Pharmaceutical INC. $20.19 2022
Aimmune Therapeutics, INC. $19.85 2024
Dexcom, INC. $19.62 2024 Dexcom G6 Transmitter
Celgene Corporation $19.52 2019
Idorsia Pharmaceuticals US INC $19.43 2023 Quviviq
Philips North America LLC $18.95 2020
Sanofi-Aventis U.S. LLC $18.24 2019
Linus Health, INC. $17.93 2023
Alvogen INC $17.81 2025 Teriparatide
Currax Pharmaceuticals LLC $16.57 2022
Otsuka Pharmaceutical Development & Commercialization, INC. $16.56 2025 Rexulti
Tanabe Pharma America, INC. $16.22 2022
Nabriva Therapeutics, Plc $16.11 2020
Otsuka America Pharmaceutical, INC. $16.00 2023 Nuedexta
Acella Pharmaceuticals, LLC $14.60 2024 NP Thyroid 60
Janssen Pharmaceuticals, INC $14.24 2019
Azurity Pharmaceuticals, INC. $13.31 2023 Adthyza
Sanofi Pasteur INC. $13.24 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Valeri Koganski

$17,082.46

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $2,016 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/330586/valeri-koganski

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.